Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.8543
-0.0557 (-6.12%)
At close: Jul 16, 2026, 4:00 PM EDT
0.8400
-0.0143 (-1.67%)
After-hours: Jul 16, 2026, 7:55 PM EDT
Fractyl Health Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
135.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 93.00K | -27.00K | -22.50% |
| Dec 31, 2023 | 120.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fortress Biotech | 66.16M |
| Cue Biopharma | 32.73M |
| Seer, Inc. | 15.17M |
| Spruce Biosciences | 697.00K |
| Genelux | 8.00K |
GUTS News
- 1 day ago - Fractyl Health Transcript: Study result - Transcripts
- 1 day ago - Fractyl Health Press release: Study result - Filings
- 1 day ago - Fractyl Health Slides: Study result - Filings
- 1 day ago - Fractyl Health reports results from REMAIN-1 Midpoint Cohort - TheFly
- 1 day ago - Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation - GlobeNewsWire
- 15 days ago - Craig-Hallum bullish on Fractyl Health, initiates with a Buy - TheFly
- 15 days ago - Fractyl Health initiated with a Buy at Craig-Hallum - TheFly
- 5 weeks ago - Fractyl Health Transcript: AGM 2026 - Transcripts